<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Drug Discovery</title>
    <link rel="stylesheet" href="style3.css">
    <link href="https://fonts.googleapis.com/css2?family=Roboto:wght@300;400;700&family=Lora:wght@400;700&display=swap" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css2?family=Inter+Tight:wght@300;400;700&display=swap" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.5.2/css/all.min.css">
    <script async src="https://www.googletagmanager.com/gtag/js?id=G-38PESE35X3"></script>
    <script>
      window.dataLayer = window.dataLayer || [];
      function gtag(){dataLayer.push(arguments);}
      gtag('js', new Date());
      gtag('config', 'G-38PESE35X3');
    </script>

</head>
<body style="background-color: rgb(255, 255, 255); padding-top: 100px;">
    <a href="https://tibbtech.com/" target="_blank">
    <div id="navbar" class="noto">
            <img src="logo.svg" style="height: 100%;" />
            <!-- <div onclick="toggleNav(event)">
                <svg xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 24 24" stroke-width="1.5" stroke="currentColor" style="width: 30px; height: 30px; cursor: pointer">
                    <path stroke-linecap="round" stroke-linejoin="round" d="M3.75 6.75h16.5M3.75 12h16.5m-16.5 5.25h16.5" />
                </svg>              
            </div> -->
        </div>
    </a>
    <!-- <div id="hidden-nav"> 
        <div onclick="toggleNav()" style="position: absolute; top: 10px; right: 30px">
            <svg xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 24 24" stroke-width="1.5" stroke="currentColor" style="width: 20px; height: 20px;">
                <path stroke-linecap="round" stroke-linejoin="round" d="M6 18 18 6M6 6l12 12" />
            </svg>              
        </div>  
        <div onclick="scrollEle('about')">About</div>
        <div onclick="scrollEle('contact-section')">Contact</div>
        <div onclick="scrollEle('team')">Team</div>
    </div> -->

    <main class="main-container">
        <section class="hero">
            <div class="hero-content">
                <div class="info-container">
                <div class="hero-title">Multimodal End-to-End Drug Discovery</div>
                <div class="hero-sub-title">
                    Introducing our cutting-edge multimodal drug discovery framework, seamlessly integrating 2D, 3D, and 4D analyses to accelerate the discovery of novel therapies, from molecular insights to behavioral outcomes.                </div>
                    <!-- <p class="author-info">By Qazi & Asim</p> -->
                    <!-- <p class="author-info">June 18, 2024</p> -->
                </div>
            
                <div class="slider">
                    <video controls autoplay muted loop id="DD_video" class="video">
                        <source src="asim.mp4" type="video/mp4">
                        Your browser does not support the video tag.
                    </video>
                </div>
        </div>
        </section>
        
        <section class="content">
            <article class="post">
                <div class="post-container">
                    <div class="post-text-2">
                        <p>
                            In the complex and high-stakes world of drug discovery, the journey from initial concept to a viable 
                            therapeutic solution is fraught with challenges. Traditional methods, often relying on isolated 
                            techniques and siloed processes, struggle to keep pace with the growing demand for speed, accuracy, 
                            and innovation. This is particularly critical in the realm of brain disorders, where the urgency to 
                            discover effective therapies is heightened by the growing prevalence of conditions like Alzheimer’s, 
                            Parkinson’s, and epilepsy. According to the Tufts Center for the Study of Drug Development, the 
                            average cost of bringing a new drug to market now exceeds <b>$2.6 billion</b>, and the process can take over 
                            a decade to complete. Yet, despite these enormous investments, the success rate remains alarmingly 
                            low. A report from the Biotechnology Innovation Organization (BIO) reveals that only <b>1 in 8</b> drug 
                            candidates that enter clinical trials will ultimately receive FDA approval. This fragmented approach 
                            slows down the pipeline and limits the potential for breakthroughs, leaving wet labs overburdened and 
                            under-supported. 
                        </p>
                    </div>
                </div>
            </article>

            <article class="post">
                <div class="post-container">
                    <div class="post-text-2">
                        <h3>The statistics are staggering</h3>
                        <p>
                            Only <b>1 in 5,000</b> compounds that enter preclinical testing make it to human trials, reflecting the 
                            immense challenges researchers face from the earliest stages of drug discovery. This is particularly 
                            concerning in the context of brain disorders, which affect millions globally. For example, Alzheimer’s
                            disease alone affects over <b>50 million</b> people worldwide, with that number expected to triple by 2050, 
                            according to the World Health Organization (WHO). In the United States, nearly <b>6 million</b> people live 
                            with Alzheimer’s, and the economic burden of brain disorders is projected to exceed <b>$1 trillion</b> 
                            annually by 2030, as reported by the National Institutes of Health (NIH). Parkinson’s disease, 
                            another major brain disorder, impacts over <b>10 million</b> people globally, with around <b>60,000</b> new cases 
                            diagnosed each year in the U.S. Epilepsy, affecting over <b>50 million</b> people worldwide, is one of the 
                            most common neurological diseases globally, with the economic impact in the U.S. alone estimated to 
                            be around <b>$15.5 billion</b> annually. Traditional wet lab environments, though essential, are often 
                            bogged down by the need to repeatedly validate findings across various stages of the discovery 
                            process. This lack of integration between computational and experimental approaches leads to data 
                            silos, where insights gained in one phase may not effectively inform the next, resulting in 
                            inefficiencies and increased risks of errors. Moreover, the shift from 2D cell cultures to 3D 
                            models—and eventually to complex 4D data—adds further complexity, demanding a level of precision 
                            and coordination that many current systems struggle to provide. With high costs, lengthy timelines, 
                            and increasing pressure to innovate, the obstacles facing biologists in drug discovery, especially 
                            for brain disorders, are both significant and multifaceted.                 
                            <br><br>
                            In an era where precision, efficiency, and innovation are paramount, particularly in 
                            the fight against brain disorders, the industry desperately needs a unified, multimodal end-to-end 
                            solution that seamlessly integrates diverse methodologies. Such a solution would allow researchers to 
                            harness the full spectrum of all modalities, transforming the way we discover and 
                            develop new drugs, and reducing both the time and cost associated with bringing life-saving therapies 
                            to market.
        
                <br><br>
                <article>
                    <div class="post-container">
                        <div class = "post-text-2">
                            <h3>Introducing your wet lab’s multimodal co-pilot</h3>
                    <p>
                        Our platform acts as a comprehensive co-pilot in drug discovery, integrating advanced tools and 
                        methodologies across 2D, 3D, and 4D domains to support and enhance your wet lab capabilities. This 
                        integration allows for a seamless transition between different phases of drug development, ensuring 
                        that every piece of data is accurately captured and analyzed.
                    </p>
                    <br>
                    <h4>
                        Neuron Segmentation
                    </h4>
                    <!-- <img src="slider.gif" class="gif" alt="Slider Animation"> -->
                    <p>
                        In the 2D domain, our platform excels at processing high-resolution brain slices, allowing for detailed 
                        neuron segmentation and brain mapping. Utilizing a state-of-the-art neuron segmentation tool that operates
                        effectively with minimal training data, we ensure precise identification and delineation of neuronal 
                        structures in 2D images. This segmentation is crucial for understanding the organization and distribution 
                        of neurons within brain slices, facilitating subsequent analysis and comparison. Moreover, our platform 
                        supports the identification of specific neuronal subtypes through enhancer-based labeling techniques, 
                        enabling researchers to target and study distinct populations of neurons within the brain.

                        <img src="giffy.gif" class="gif" alt="Slider Animation">
                    </p>
                    <p>
                        When it comes to 3D analysis, our platform extends its capabilities to volumetric brain imaging, 
                        offering advanced tools for segmenting and analyzing entire brain volumes. The same neuron segmentation 
                        technology used in 2D is applied to 3D datasets, allowing for the precise identification of neuronal 
                        structures within the entire brain volume. This 3D segmentation is vital for understanding the spatial 
                        relationships and connectivity between neurons, providing insights into brain function and pathology. 
                        Additionally, our platform facilitates brain-wide gene expression quantification, enabling researchers 
                        to correlate gene expression patterns with specific neuronal circuits and behaviors, thereby enhancing 
                        the understanding of the molecular mechanisms underlying brain function.
                        <img src="3dgiffy.gif" class="gif" alt="Slider Animation">
                        <br>
                    </p>

                    <h4>Brain Registration</h4>
                    <p>
                        Our platform also supports accurate brain registration, aligning 2D slices to standardized brain atlases. 
                        This process ensures that different brain slices can be compared and integrated into a coherent dataset, 
                        enabling researchers to study variations in neuronal architecture and correlate them with specific brain 
                        regions. Through robust 3D brain registration, our platform aligns volumetric data to standardized 3D 
                        brain atlases, essential for comparing brain volumes across different conditions or time points. This 
                        capability is particularly crucial when analyzing data from multi-center studies, where variations in 
                        imaging protocols and equipment can introduce inconsistencies. Our registration techniques are designed 
                        to be resilient to these variations, ensuring that the anatomical integrity of the brain is preserved, 
                        and enabling researchers to detect subtle changes in brain structure and function that may result from 
                        drug interventions or disease progression.
                        <img src="reg_brain.gif" class="gif" alt="Slider Animation">
                        <br>
                    </p>
                    <h4>
                        Behavioral Analytics
                    </h4>
                    <p>
                        
                        Our platform also incorporates behavioral video analytics to assess drug efficacy in 
                        real-time. This involves analyzing video data that captures dynamic behavioral changes over time, 
                        providing a temporal dimension to traditional 2D and 3D analyses. By tracking and quantifying animal 
                        behavior in response to drug treatments, our platform helps researchers understand how these 
                        interventions affect overall behavior and neurological function. This 4D analysis is particularly 
                        valuable for studying the efficacy of drugs intended to modify behavior or neurological outcomes. 
                        It allows for the identification of subtle behavioral changes that may not be apparent in static 2D or 
                        3D analyses, offering a more comprehensive assessment of a drug’s impact. The ability to correlate 
                        these behavioral changes with underlying neuronal activity and gene expression profiles makes our 
                        platform an indispensable tool for advancing neuropharmacology.

                    <img src="4dgiffy.gif" class="gif" alt="Slider Animation">

                    </p>
                    <br>
                    <br>

                    <h4>
                        Integrated Approach
                    </h4>
                    <p>
                        By combining multiple modalities, our platform provides a unified, multimodal approach to 
                        drug discovery. Whether you’re segmenting neurons in brain slices, analyzing whole brain volumes, or 
                        assessing behavioral outcomes in real-time, our platform offers the tools and precision needed to drive 
                        innovation in drug development. This integration ensures that every stage of your research is supported 
                        by robust data and cutting-edge technology, empowering you to advance new therapies with confidence and 
                        efficiency. The ability to integrate multi-omic data, including gene expression and epigenetic 
                        modifications, further enhances the platform’s capacity to uncover the complex biological underpinnings 
                        of disease, paving the way for the development of highly targeted therapeutic interventions.
                    </p>
                    
                        </div>
                    </div>
                </article>

            <br>
            <article class="post">
                <div class="post-container">
                    
                    <div class="post-text-2">
                        <h3>The future</h3>
                    
                        <p>
                            The future of drug discovery hinges on the seamless integration of advanced technologies with 
                            traditional wet lab techniques. As the field evolves, so too must the tools we use to navigate 
                            its complexities. Our multimodal platform represents not just a technological advancement, but a 
                            paradigm shift in how we approach the discovery and development of new therapies. By uniting 2D, 
                            3D, and 4D data within a single, cohesive framework, we ensure that every insight is captured, every 
                            opportunity is leveraged, and no time is wasted.

                            <br><br>
                            As a co-pilot to your wet lab, our platform empowers you to overcome the inherent challenges of 
                            modern drug discovery, delivering faster, more accurate results. This transformation is not merely 
                            about accelerating processes—it’s about making drug discovery more precise, integrated, and capable 
                            of achieving the breakthroughs that will define the next era of medicine. The ability to conduct 
                            comprehensive analyses, from neuron segmentation to behavioral assessments, within a unified 
                            platform, enables researchers to approach drug discovery holistically, ensuring that every aspect of 
                            the research is informed by the latest advancements in technology and science.

                            <br><br>
                            In the coming years, the integration of artificial intelligence with multimodal data analysis will 
                            further enhance the platform’s capabilities, enabling predictive modeling and the identification of 
                            novel therapeutic targets. This approach will not only accelerate drug discovery but also increase 
                            the likelihood of clinical success, ultimately leading to more effective and personalized treatments 
                            for patients worldwide.
                        </p>
                    </div>
                </div>
            </article>


            <article>
                <div class="post-container">
                    <div class = "post-text-2">
                        <h3>Our platform is more than just a tool</h3>
                        <p>
                            Our platform a game-changer in the world of drug discovery. 
                            By providing a comprehensive suite of advanced technologies that span 2D, 3D, and 4D domains, we 
                            empower researchers to conduct their work with unprecedented precision and efficiency. From neuron 
                            segmentation and brain registration to behavioral analytics, our platform ensures that every aspect 
                            of drug discovery is supported by the most advanced tools available.

                            <br><br>
                            With our platform as your co-pilot, you can navigate the complexities of drug discovery with 
                            confidence, knowing that you have the tools you need to drive innovation and deliver groundbreaking 
                            therapies to patients faster than ever before. The integration of multi-omic analyses, combined with 
                            cutting-edge imaging and behavioral assessment tools, positions our platform as an essential asset in 
                            the pursuit of medical breakthroughs. As we continue to refine and expand our capabilities, we remain 
                            committed to supporting researchers in their quest to improve human health and transform the future of 
                            medicine.
                            
                            <br><br>
                            This expanded content emphasizes the technical depth of the platform, highlighting its capabilities in 
                            a way that resonates with professionals in the field. It also underscores the platform’s role in 
                            integrating various aspects of drug discovery, from molecular to behavioral analysis.                        </p>  
                    </div>
                </div>
            </article>
            
            <article>
                <div class="learn-more">
                    <h2>Learn more about our work</h2>
                    <div class="slider-2">        
                        <a href="https://www.biorxiv.org/content/biorxiv/early/2024/07/22/2024.07.17.603924.full.pdf" target="_blank">
                            <div class="card">
                                <div class="card-header">
                                    <img src="dd.png" alt="drug discovery" class="card-logo">
                                </div>
                                <div class="card-body">
                                    <p class="card-date">2024</p>
                                    <h3>An enhancer-AAV toolbox to target and manipulate distinct interneuron subtypes</h3>
                                    <p class="card-participant" style="text-align: left;">
                                        Elisabetta Furlanis, Min Dai, Brenda Leyva Garcia, Josselyn Vergara, Ana Pereira, Kenneth Pelkey, Thien Tran....
                                    </p>
                                </div>
                            </div>
                        </a>

                        <a href="https://www.biorxiv.org/content/biorxiv/early/2024/05/17/2024.05.17.594691.full.pdf" target="_blank">
                            <div class="card">
                                <div class="card-header">
                                    <img src="cellseg3d.png" alt="drug discovery" class="card-logo">
                                </div>
                                <div class="card-body">
                                    <p class="card-date">2024</p>
                                    <h3>CellSeg3D: self-supervised 3D cell segmentation for microscopy</h3>
                                    <p class="card-participant" style="text-align: left;">
                                        Cyril Achard, Timokleia Kousi, Markus Frey, Maxime Vidal, Yves Paychere, Colin Hofmann, Asim Iqbal, Sebastien B Hausmann, Stephane Pages, Mackenzie W Mathis
                                    </p>
                                </div>
                            </div>
                        </a>

                        <a href="https://ieeexplore.ieee.org/abstract/document/10222341" target="_blank">
                            <div class="card">
                                <div class="card-header">
                                    <img src="3d brain reg.png" alt="drug discovery" class="card-logo">
                                </div>
                                <div class="card-body">
                                    <p class="card-date">2023</p>
                                    <h3>3D Brain Registration with Intensity Shift Robustness</h3>
                                    <p class="card-participant" style="text-align: left;">
                                        Hassan Mahmood, Asim Iqbal, Syed Mohammed Shamsul Islam, Syed Afaq Ali Shah
                                    </p>
                                </div>
                            </div>
                        </a>

                        <!-- <a href="https://ieeexplore.ieee.org/abstract/document/10222341" target="_blank">
                            <div class="card">
                                <div class="card-header">
                                    <img src="segmentanyNeuron.png" alt="MIT Logo" class="card-logo">
                                </div>
                                <div class="card-body">
                                    <p class="card-date">2023</p>
                                    <h3>Segment AnyNeuron</h3>
                                    <p class="card-participant" style="text-align: left;">
                                        Taha Razzaq, Ahmed Qazi, Asim Iqbal
                                    </p>
                                </div>
                            </div>
                        </a> -->
                        </div>
                    </div>
                </div>
                


            </article>





            <article>
                <div class="post">
                    <h2 class="second-description">Publications</h2>
                    <div class="list-container" id="publication-lists"></div>
                    <div class="show-buttons">
                        <button class="list-show-more" id="show-more" style="display: none;">Show More</button>
                        <button class="list-show-less" id="show-less" style="display: none;">Show Less</button>
                    </div>
                    </div>
                </div>
                
            </article>
                                                   
                            
    </main>
    <footer>
        <div class="footer-container center-col" style="margin-top: 30px;">
            <!-- <div class="social-follow">
                <span>Follow us on</span>
                <a href="https://x.com/tibbtech?mx=2" target="_blank"><i class="fa-brands fa-x-twitter"></i></a>
            </div> -->
            © Tibbling Technologies · All Rights Reserved
        </div>
    </footer>

    <script src="publications.js"></script>

    

    <script>
      
    
    document.addEventListener("DOMContentLoaded", () => {
    let lastScrollTop = 0; // Variable to store the last scroll position
    const navbar = document.getElementById('navbar'); // Get the navbar element
    
    window.addEventListener("scroll", function() {
        let scrollTop = window.pageYOffset || document.documentElement.scrollTop;
        
        if (scrollTop > lastScrollTop) {
            // Downscroll code
            navbar.style.top = "-15rem"; // Adjust this value to match the navbar's height
        } else {
            // Upscroll code
            navbar.style.top = "0px";
        }
        lastScrollTop = scrollTop <= 0 ? 0 : scrollTop; // Update lastScrollTop to current position
    }, false);
    });
    
        var nav_open = false
        let hidden_nav = document.getElementById("hidden-nav");
    
        document.addEventListener('click', (e) => {
            if (nav_open && !hidden_nav.contains(e.target)) {
                toggleNav();
            }
        });
    
        function toggleNav(e) {
            nav_open = hidden_nav.style.right == "0px";
            hidden_nav.style.right = nav_open ? "-300px" : "0px";
            nav_open = !nav_open;
            e?.stopPropagation();
        }
    
        function scrollEle(ele) {
            toggleNav();
            document.getElementById(ele).scrollIntoView({behavior: 'smooth', block: "center", inline: "nearest"});
        }
    
    
                                            // Reset scroll behavior when scrolled to top
                                            window.addEventListener('scroll', function() {
                                            if (window.scrollY <= 50) {
                                                allowScroll = true; // Re-enable scrolling when the user scrolls back to the top
                                            }
                                        });
    
                                        document.addEventListener('DOMContentLoaded', function() {
                                        var navbar = document.getElementById('navbar');
                                        window.addEventListener('scroll', function() {
                                            // Add 'scrolled' class to the navbar based on the scroll position
                                            if (window.pageYOffset > 250) {
                                                navbar.classList.add('scrolled');
                                            } else {
                                                navbar.classList.remove('scrolled');
                                            }
                                        });
                                    });



    
    //for truncated cards
    const cards = document.querySelectorAll('.card-participant');
    const maxLength = 100; // Adjust the character limit as needed

    cards.forEach(card => {
        const fullText = card.getAttribute('data-full-text');
        
        if (fullText.length > maxLength) {
            const truncatedText = fullText.substring(0, maxLength) + '...';
            card.textContent = truncatedText;
        }
    });
    
    
    </script>



    <script>
   document.addEventListener('DOMContentLoaded', function () {
    const maxLength = 120; // Set the maximum number of characters

    document.querySelectorAll('.card-participant').forEach(function(cardParticipant) {
        const fullText = cardParticipant.textContent.trim();

        if (fullText.length > maxLength) {
            const truncatedText = fullText.substring(0, maxLength) + '...';
            cardParticipant.innerHTML = truncatedText;
        }
    });
});

</script>    
        
<script>
    document.getElementById('DD_video').playbackRate = 2.0;
</script>
    
</body>
</html>
